ナポリ・シュコルニク弁護士 ロゴ

​​URGENT: Oxbryta® Withdrawn from Market – Severe Side Effects Linked to VOCs and Fatalities – File Your Claim Now!

If you or a loved one were prescribed OXBRYTA for sickle cell disease and experienced worsening symptoms or complications, you may be entitled to compensation. Our attorneys are dedicated to holding Pfizer accountable, and we are here to fight for the recovery you deserve.

Act now for a FREE, confidential case evaluation!

始める 無料 ケース評価

以下の簡単なフォームに記入してください。

ステップ 16

このフィールドは検証用であり、変更しないでください。
Were you or a loved one prescribed Oxbyrta?(必須)

Oxbryta and Vaso-Occlusive Crisis: What You Need to Know

Oxbryta (voxelotor), a drug prescribed for sickle cell disease, was recently voluntarily withdrawn from the global market by Pfizer due to alarming safety concerns. While Oxbryta was originally hailed as a breakthrough in the treatment of sickle cell disease, studies have revealed that its use may actually significantly increase the risk of dangerous complications including vaso-occlusive crises (VOCs), or even death. 

Patients and families affected by these severe side effects may be eligible to file a lawsuit against Pfizer to seek compensation for their suffering.

 If you or a loved one have been affected, it’s crucial to act now.

Serious Side Effects of Oxbryta:

  • Vaso-Occlusive Crises (VOCs): Oxbryta has been shown to increase the frequency of VOC which is severe pain caused by sickled red blood cells blockingblood flow and oxygen delivery to tissues, a dangerous complication of sickle cell disease where sickled red blood cells block blood flow to organs, causing extreme pain and potential long-term damage such as kidney failure and stroke​.
  • Fatalities: Clinical trials and post-market reports indicated a higher death rate among patients using Oxbryta, raising serious concerns about the drug’s safety protocols. In one study involving children, there were 8 deaths in the Oxbryta group compared to only 2 in the control group​.

These conditions can require extensive medical treatments, surgeries, and long-term care, all of which may be compensated through legal action.

 
無料のケース評価を開始する
 

Case Eligibility

Am I Eligible to File a Claim? You may be eligible to file a lawsuit if you:

    • Were prescribed Oxbryta for sickle cell disease.
    • Have been diagnosed with VOCs 
    • Have experienced medical expenses, lost wages, or ongoing health complications related to the VOCs
    • Or if Oxbryta has caused death in the family

Napoli Shkolnik will review your case at no cost to ensure that you meet the legal requirements for filing a claim.

Why File a Claim Now?

    • Time-Sensitive: Legal deadlines may apply, so it’s important to act quickly.
    • Compensation: Secure financial compensation for medical expenses, lost wages, and pain and suffering.
    • Justice: Hold Pfizer accountable for failing to warn about the risks.
Serious black woman

Why Hold the Manufacturer Pfizer Accountable?

Pharmaceutical companies have a responsibility to ensure their products are safe. When Big Pharma fails to adequately test their products or warn users of potential risks, they must be held accountable. By taking legal action, you can:

  • Seek Compensation: Cover medical expenses, lost wages, and other damages related to your VOC diagnosis. 
  • Raise Awareness: Help prevent other women from suffering similar issues by bringing attention to the risks associated with Oxbryta.
  • Promote Safer Practices: Encourage pharmaceutical companies to prioritize safety and transparency in their product development processes.

Steps to Join the This Lawsuit

If you have been diagnosed with VOC after taking Oxbryta, follow these steps to join the lawsuit and seek compensation:

1.

お問い合わせ: Fill out the form above to schedule a free, no-obligation consultation.

2.

Provide Details: Share your experience with this prescription, including any medical records and documentation of your VOC diagnosis.

3.

Legal Evaluation: Our experienced attorneys will evaluate your case and determine the best course of action.

4.

Pursue Justice: We will guide you through the legal process, fighting tirelessly to secure the compensation you deserve.

Get Started

よくある質問

Oxbryta (voxelotor), a drug prescribed for sickle cell disease

If you have been administered Oxybrta for sickle cell disease and diagnosed with VOCs, may be eligible to file a claim.

Compensation may cover medical bills, lost wages, pain and suffering, future medical care, and more, depending on the severity of the case.

Napoli Shkolnik works on a contingency basis, meaning you pay nothing unless we win your case.

Yes, all information shared with us is completely confidential and protected by attorney-client privilege.

Award-Winning National Pharmaceutical Litigation Firm

Best Lawyers® "Best Law Firms" - Product Liability 2024
Best Law Firms in the United States
全国裁判弁護士賞
Serious black woman

Why Choose Napoli Shkolnik?

  • Experienced Attorneys: Our team specializes in pharmaceutical litigation, bringing expertise and dedication to your case.
  • No Upfront Fees: We work on a contingency fee basis, meaning you don’t pay unless we win your case.
  • Personalized Attention: We provide compassionate and individualized attention, understanding the impact of your suffering and fighting tirelessly for your rights.

Don’t let serious injuries from Oxbryta use disrupt your life any longer. Reach out to Napoli Shkolnik today and take the first step towards justice.

無料のケース評価を開始する

Expertise in 医薬品訴訟

Over 20 years of experience handling complex cases related to prescription medications.

Proven Results

 

Billions recovered for clients in pharmaceutical cases, including Oxbryta lawsuits.

No Fees Unless We Win

 

We operate on a contingency basis, ensuring you face no upfront costs.

Copyright © 2024 | All Rights Reserved | プライバシーポリシー利用規約.搭載 レモネードスタンド.

Napoli Shkolnik は、プエルトリコの有限責任会社である NSPR Legal Services LLC の登録商標です。

弁護士の広告。このウェブサイトの情報は、一般的な情報提供のみを目的としています。このサイトの内容は、個々のケースまたは状況に対する法的助言として解釈されるべきではありません。この情報は、作成することを意図したものではなく、受信または表示は、弁護士とクライアントの関係を構成するものではありません.このサイトに記載されている過去の結果は、将来の結果を保証するものではありません。

参考文献: 2021 study:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561257/ 4新しい研究では、黒髪のヘアケア製品に含まれる化学物質が乳がんのリスクを高めることが明らかになった